litlas
Log inCreate account

David E. Fisher

Active 1969–2025

184
Papers
44,402
Citations
110
h-index
181
i10-index

Citations

Citations per year for David E. Fisher1969: 1 citations1970: 1 citations1971: 5 citations1972: 6 citations1973: 6 citations1974: 5 citations1975: 1 citations1976: 9 citations1977: 2 citations1978: 2 citations1980: 3 citations1981: 2 citations1982: 5 citations1983: 8 citations1984: 9 citations1985: 13 citations1986: 15 citations1987: 6 citations1988: 9 citations1989: 5 citations1990: 6 citations1991: 7 citations1992: 6 citations1993: 24 citations1994: 26 citations1995: 62 citations1996: 117 citations1997: 115 citations1998: 132 citations1999: 157 citations2000: 176 citations2001: 206 citations2002: 217 citations2003: 226 citations2004: 266 citations2005: 223 citations2006: 362 citations2007: 284 citations2008: 405 citations2009: 408 citations2010: 433 citations2011: 435 citations2012: 396 citations2013: 488 citations2014: 557 citations2015: 475 citations2016: 417 citations2017: 468 citations2018: 492 citations2019: 1,375 citations2020: 1,586 citations2021: 1,513 citations2022: 1,137 citations2023: 893 citations2024: 1,331 citations2025: 640 citations2026: 16 citations1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,513 citing papers, 31.1% of this breakdownChina: 2,077 citing papers, 11.7% of this breakdownUnited Kingdom: 964 citing papers, 5.4% of this breakdownGermany: 936 citing papers, 5.3% of this breakdownItaly: 805 citing papers, 4.5% of this breakdownFrance: 694 citing papers, 3.9% of this breakdownJapan: 617 citing papers, 3.5% of this breakdownAustralia: 585 citing papers, 3.3% of this breakdownCanada: 445 citing papers, 2.5% of this breakdownSouth Korea: 391 citing papers, 2.2% of this breakdownNetherlands: 382 citing papers, 2.2% of this breakdownSpain: 381 citing papers, 2.1% of this breakdown
0%31.1%Other 22.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology51.8%
  • Medicine35%
  • Immunology and Microbiology5.8%
  • Neuroscience1.5%
  • Engineering1.3%
  • Computer Science0.7%
  • Other3.9%

Topics

  • melanin and skin pigmentation4.1%
  • Melanoma and MAPK Pathways3.9%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Immunotherapy and Immune Responses3%
  • CAR-T cell therapy research2.3%
  • Cutaneous Melanoma Detection and Management2.3%
  • Other80.7%

Coauthors

All papers

Open in search
  1. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

    Authors: Robert T. Manguso, Hans W. Pope, Margaret D. Zimmer, Flavian D. Brown, Kathleen B. Yates, Brian C. Miller, Natalie B. Collins, Kevin Bi, Martin W. LaFleur, Vikram R. Juneja, Sarah A. Weiss, Jennifer A. Lo, David E. Fisher, Diana Miao, Eliezer M. Van Allen, David E. Root, Arlene H. Sharpe, John G. Doench, W. Nicholas Haining - Nature 2017 cited by 1,172

  2. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy

    Authors: Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, Dennie T. Frederick, Jennifer A. Lo, David E. Fisher, Gordon J. Freeman, Genevieve M. Boland, Andrew D. Luster - Immunity 2019 cited by 710

  3. B-cell-specific checkpoint molecules that regulate anti-tumour immunity

    Authors: Lloyd Bod, Yoon-Chul Kye, Jingwen Shi, Elena Torlai Triglia, Alexandra Schnell, Johannes Fessler, Stephen M. Ostrowski, Max von Franque, Juhi R. Kuchroo, Rocky Barilla, Sarah Zaghouani, Elena Christian, Toni Delorey, Kanishka Mohib, Sheng Xiao, Nadine Slingerland, Christopher J. Giuliano, Orr Ashenberg, Zhaorong Li, David M. Rothstein, David E. Fisher, Orit Rozenblatt–Rosen, Arlene H. Sharpe, Francisco J. Quintana, Lionel Apétoh, Aviv Regev, Vijay K. Kuchroo - Nature 2023 cited by 168

  4. Melanocyte biology and skin pigmentation

    Authors: Jennifer Y. Lin, David E. Fisher - Nature 2007 cited by 1,365

  5. NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer

    Authors: Tommy Weiss‐Sadan, Maolin Ge, Makiko Hayashi, Magdy Gohar, Cong-Hui Yao, Adriaan de Groot, Stefan Harry, Alexander Carlin, Hannah Fischer, Lei Shi, Ting-Yu Wei, Charles H. Adelmann, Konstantin Wolf, Tristan Vornbäumen, Benedikt R. Dürr, Mariko Takahashi, Marianne Richter, Junbing Zhang, Tzu-yi Yang, Vindhya Vijay, David E. Fisher, Aaron N. Hata, Marcia C. Haigis, Raúl Mostoslavsky, Nabeel Bardeesy, Thales Papagiannakopoulos, Liron Bar‐Peled - Cell Metabolism 2023 cited by 144

  6. Targeting TBK1 to overcome resistance to cancer immunotherapy

    Authors: Yi Sun, Or‐Yam Revach, Seth Anderson, Emily Kessler, Clara Wolfe, Anne Jenney, Caitlin E. Mills, Emily Robitschek, Thomas Davis, Sarah Kim, Amina Fu, Xiang Ma, Jia Gwee, Payal Tiwari, Peter P. Du, Princy Sindurakar, Jun Tian, Arnav Mehta, Alexis M. Schneider, Keren Yizhak, Moshe Sade-Feldman, Thomas J. LaSalle, Tatyana Sharova, Hongyan Xie, Shuming Liu, William A. Michaud, Rodrigo Saad-Beretta, Kathleen B. Yates, Arvin Iracheta‐Vellve, Johan Spetz, Xingping Qin, Kristopher A. Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y. Su, Angelina M. Cicerchia, Martin Q. Rasmussen, Samuel J. Klempner, Dejan Juric, Sara I. Pai, David M. Miller, Anita Giobbie‐Hurder, Jonathan Chen, Karin Pelka, Dennie T. Frederick, Susanna Stinson, Elena V. Ivanova, Amir Reza Aref, Cloud P. Paweletz, David A. Barbie, Debattama R. Sen, David E. Fisher, Ryan B. Corcoran, Nir Hacohen, Peter K. Sorger, Keith T. Flaherty, Genevieve M. Boland, Robert T. Manguso, Russell W. Jenkins - Nature 2023 cited by 167

  7. Melanoma

    Authors: Dirk Schadendorf, David E. Fisher, Claus Garbe, Jeffrey E. Gershenwald, Jean‐Jacques Grob, Allan C. Halpern, Meenhard Herlyn, Michael A. Marchetti, Grant A. McArthur, Antoni Ribas, Alexander Roesch, Axel Hauschild - Nature Reviews Disease Primers 2015 cited by 603

  8. Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF

    Authors: Rizwan Haq, Jonathan E. Shoag, Pedro Andreu-Pérez, Satoru Yokoyama, Hannah Edelman, Glenn C. Rowe, Dennie T. Frederick, Aeron D. Hurley, Abhinav Nellore, Andrew L. Kung, Jennifer A. Wargo, Jun S. Song, David E. Fisher, Zoltàn Arany, Hans R. Widlund - Cancer Cell 2013 cited by 815

  9. Hyperactivation of sympathetic nerves drives depletion of melanocyte stem cells

    Authors: Bing Zhang, Sai Ma, Inbal Rachmin, Megan He, Pankaj Baral, Sekyu Choi, William Antônio Gonçalves, Yulia Shwartz, Eva M. Fast, Yiqun Su, Leonard I. Zon, Aviv Regev, Jason D. Buenrostro, Thiago M. Cunha, Isaac M. Chiu, David E. Fisher, Ya‐Chieh Hsu - Nature 2020 cited by 291

  10. Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

    Authors: Kensuke Tateishi, Hiroaki Wakimoto, A. John Iafrate, Shota Tanaka, Franziska Loebel, Nina Lelic, Dmitri Wiederschain, Olivier Bedel, Gejing Deng, Bailin Zhang, Timothy He, Xu Shi, Robert E. Gerszten, Yiyun Zhang, Jing-Ruey Joanna Yeh, William T. Curry, Dan Zhao, Sudhandra Sundaram, Fares Nigim, Mara V.A. Koerner, Quan Van Ho, David E. Fisher, Elisabeth Roider, Lajos V. Kemény, Yardena Samuels, Keith T. Flaherty, Tracy T. Batchelor, Andrew S. Chi, Daniel P. Cahill - Cancer Cell 2015 cited by 445

  11. Skin pigmentation and its control: From ultraviolet radiation to stem cells

    Authors: Joseph Michael Yardman‐Frank, David E. Fisher - Experimental Dermatology 2020 cited by 189

  12. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

    Authors: Levi A. Garraway, Hans R. Widlund, Mark A. Rubin, Gad Getz, Aaron J. Berger, Sridhar Ramaswamy, Rameen Beroukhim, Danny A. Milner, Scott R. Granter, Jinyan Du, Charles Lee, Stephan N. Wagner, Cheng Li, Todd R. Golub, David L. Rimm, Matthew L. Meyerson, David E. Fisher, William R. Sellers - Nature 2005 cited by 1,539

  13. BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

    Authors: Dennie T. Frederick, Adriano Piris, Alexandria P. Cogdill, Zachary A. Cooper, Cecilia Lezcano, Cristina R. Ferrone, Devarati Mitra, Andrea Boni, Lindsay P. Newton, Chengwen Liu, Weiyi Peng, Ryan J. Sullivan, Donald P. Lawrence, F. Stephen Hodi, Willem W. Overwijk, Gregory Lizée, Gëorge F. Murphy, Patrick Hwu, Keith T. Flaherty, David E. Fisher, Jennifer A. Wargo - Clinical Cancer Research 2013 cited by 938

  14. Treatment of Advanced Melanoma in 2020 and Beyond

    Authors: Russell W. Jenkins, David E. Fisher - Journal of Investigative Dermatology 2020 cited by 340

  15. The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology

    Authors: Akinori Kawakami, David E. Fisher - Laboratory Investigation 2017 cited by 314

  16. MITF: master regulator of melanocyte development and melanoma oncogene

    Authors: Carmit Levy, Mehdi Khaled, David E. Fisher - Trends in Molecular Medicine 2006 cited by 1,151

  17. Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions

    Authors: Owen S. Skinner, Joan Blanco-Fernández, Russell P. Goodman, Akinori Kawakami, Hongying Shen, Lajos V. Kemény, Lena Joesch-Cohen, Matthew G. Rees, Jennifer A. Roth, David E. Fisher, Vamsi K. Mootha, Alexis A. Jourdain - Nature Metabolism 2023 cited by 105

  18. The melanoma revolution: From UV carcinogenesis to a new era in therapeutics

    Authors: Jennifer A. Lo, David E. Fisher - Science 2014 cited by 418

  19. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    Authors: Rodabe N. Amaria, Alexander M. Menzies, Elizabeth M. Burton, Richard A. Scolyer, Michael T. Tetzlaff, Robert Antdbacka, Charlotte E. Ariyan, Roland L. Bassett, Brett Carter, Adil Daud, Mark B. Faries, Leslie A. Fecher, Keith T. Flaherty, Jeffrey E. Gershenwald, Omid Hamid, Angela Hong, John M. Kirkwood, Serigne Lo, Kim Margolin, Jane L. Messina, Michael A. Postow, Helen Rizos, Merrick I Ross, Elisa A. Rozeman, Robyn P.M. Saw, Vernon K. Sondak, Ryan J. Sullivan, Janis M. Taube, John F. Thompson, Bart A. van de Wiel, Alexander M.M. Eggermont, Michael A. Davies, Miles C. Andrews, Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shaneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long - The Lancet Oncology 2019 cited by 218

  20. Spatiotemporally resolved transcriptomics reveals the subcellular RNA kinetic landscape

    Authors: Jingyi Ren, Haowen Zhou, Hu Zeng, Connie Kangni Wang, Jiahao Huang, Xiaojie Qiu, Xin Sui, Qiang Li, Xunwei Wu, Zuwan Lin, Jennifer A. Lo, Kamal Maher, Yichun He, Xin Tang, Judson Lam, Hongyu Chen, Brian Li, David E. Fisher, Jia Liu, Xiao Wang - Nature Methods 2023 cited by 71

  21. Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

    Authors: F. Stephen Hodi, Christopher L. Corless, Anita Giobbie‐Hurder, Jonathan A. Fletcher, Mei‐Jun Zhu, Adrián Mariño‐Enríquez, Philip Friedlander, René González, Jeffrey S. Weber, Thomas F. Gajewski, Steven O’Day, Kevin B. Kim, Donald P. Lawrence, Keith T. Flaherty, Jason J. Luke, Frances A. Collichio, Marc S. Ernstoff, Michael C. Heinrich, Carol Beadling, Katherine Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, George D. Demetri, David E. Fisher - Journal of Clinical Oncology 2013 cited by 595

  22. Precision medicine for cancer with next-generation functional diagnostics

    Authors: Adam A. Friedman, Anthony Letai, David E. Fisher, Keith T. Flaherty - Nature reviews. Cancer 2015 cited by 587

  23. A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors

    Authors: David J. Konieczkowski, Cory M. Johannessen, Omar O. Abudayyeh, Jong Wook Kim, Zachary A. Cooper, Adriano Piris, Dennie T. Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq, David E. Fisher, Jill P. Mesirov, William C. Hahn, Keith T. Flaherty, Jennifer A. Wargo, Pablo Tamayo, Levi A. Garraway - Cancer Discovery 2014 cited by 536

  24. Label-free DNA imaging in vivo with stimulated Raman scattering microscopy

    Authors: Fake Lu, Srinjan Basu, Vivien Igras, Mai P. Hoang, Minbiao Ji, Dan Fu, Gary R. Holtom, Victor Neel, Christian W. Freudiger, David E. Fisher, X. Sunney Xie - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 306